Krystal Biotech (KRYS) Gross Profit (2023 - 2026)
Krystal Biotech (KRYS) posted quarterly Gross Profit of $112.8 million for Q2 2026, up 26.9% year-over-year from $88.9 million in Q2 2025, and up 2.46% on a QoQ basis from $110.1 million in Q1 2026.
Krystal Biotech (KRYS) Gross Profit (2023 - 2026) Analysis & Trends
Krystal Biotech has reported Gross Profit for 4 years, with the latest figure at $112.8 million in Q2 2026.
- Gross Profit for Q2 2026 came in at $112.8 million, up 26.9% year-over-year; the trailing twelve-month figure through Jun 2026 was $416.9 million (up 24.31% YoY), and the FY2025 annual result was $366.1 million, up 35.36% from the prior year.
- Gross Profit climbed to $112.8 million in Q2 2026, from $110.1 million in the prior quarter.
- Over five years, Gross Profit peaked at $112.8 million in Q2 2026 and troughed at $8.3 million in Q3 2023.
- A 4-year average of $75.6 million and a median of $84.7 million in 2024 frame the typical range for Gross Profit.
- The widest annual swing landed in 2024, when Gross Profit jumped 825.92%; it then gained 16.65% in 2025.
- A 4-year view of Gross Profit shows it stood at $39.3 million in 2023, then surged by 119.4% to $86.2 million in 2024, then gained by 16.65% to $100.5 million in 2025, then climbed by 12.21% to $112.8 million in 2026.
- Per Business Quant data, the three most recent Gross Profit figures were $112.8 million in Q2 2026, $110.1 million in Q1 2026, and $100.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112.79 Mn |
| Jun 30, 2026 | 112.79 Mn |
| Mar 31, 2026 | 110.08 Mn |
| Mar 31, 2026 | 110.08 Mn |
| Dec 31, 2025 | 100.51 Mn |
| Dec 31, 2025 | 100.51 Mn |
| Sep 30, 2025 | 93.54 Mn |
| Sep 30, 2025 | 93.54 Mn |
| Jun 30, 2025 | 88.88 Mn |
| Jun 30, 2025 | 88.88 Mn |
| Mar 31, 2025 | 83.16 Mn |
| Mar 31, 2025 | 83.16 Mn |
| Dec 31, 2024 | 86.19 Mn |
| Dec 31, 2024 | 86.19 Mn |
| Sep 30, 2024 | 77.16 Mn |
| Sep 30, 2024 | 77.16 Mn |
| Jun 30, 2024 | 64.29 Mn |
| Jun 30, 2024 | 64.29 Mn |
| Mar 31, 2024 | 42.83 Mn |
| Mar 31, 2024 | 42.83 Mn |